Asia-Pacific (APAC) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028
Asia-Pacific (APAC) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028
Summary
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
- The Asia-Pacific biotechnology market recorded revenues of $364.5 billion in 2023, representing a compound annual growth rate (CAGR) of 10.5% between 2018 and 2023.
- The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $220.2 billion, equivalent to 60.4% of the market's overall value.
- The Asia-Pacific biotechnology market is experiencing growth due to innovation and potential therapeutic developments. Government initiatives are driving growth in the industry, such as Japan's $3 billion investment in the Drug Development Venture Ecosystem Enhancement Project and China's emphasis on research and development.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
- What was the size of the Asia-Pacific biotechnology market by value in 2023?
- What will be the size of the Asia-Pacific biotechnology market in 2028?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Takeda Pharmaceutical Company Limited
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Astellas Pharma Inc.
8.4. Daiichi Sankyo Co Ltd
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Takeda Pharmaceutical Company Limited
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Astellas Pharma Inc.
8.4. Daiichi Sankyo Co Ltd
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
Table 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
Table 4: Asia-Pacific biotechnology industry geography segmentation: $ million, 2023
Table 5: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 11: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 12: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 13: Astellas Pharma Inc.: key facts
Table 14: Astellas Pharma Inc.: Annual Financial Ratios
Table 15: Astellas Pharma Inc.: Key Employees
Table 16: Daiichi Sankyo Co Ltd: key facts
Table 17: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 18: Daiichi Sankyo Co Ltd: Key Employees
Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 20: Asia-Pacific exchange rate, 2019-23
Table 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
Table 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
Table 4: Asia-Pacific biotechnology industry geography segmentation: $ million, 2023
Table 5: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 11: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 12: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 13: Astellas Pharma Inc.: key facts
Table 14: Astellas Pharma Inc.: Annual Financial Ratios
Table 15: Astellas Pharma Inc.: Key Employees
Table 16: Daiichi Sankyo Co Ltd: key facts
Table 17: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 18: Daiichi Sankyo Co Ltd: Key Employees
Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 20: Asia-Pacific exchange rate, 2019-23
LIST OF FIGURES
Figure 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
Figure 2: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2023
Figure 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
Figure 2: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2023
